{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T00:34:47Z","timestamp":1787445287514,"version":"build-2736575974"},"reference-count":25,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2006,6,1]],"date-time":"2006-06-01T00:00:00Z","timestamp":1149120000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Transplant Immunology"],"published-print":{"date-parts":[[2006,6]]},"DOI":"10.1016\/j.trim.2006.02.001","type":"journal-article","created":{"date-parts":[[2006,3,25]],"date-time":"2006-03-25T07:51:09Z","timestamp":1143273069000},"page":"46-51","source":"Crossref","is-referenced-by-count":44,"title":["Everolimus and reduced cyclosporine trough levels in maintenance heart transplant recipients"],"prefix":"10.1016","volume":"16","author":[{"given":"Martin","family":"Schweiger","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andre","family":"Wasler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guenther","family":"Prenner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philipp","family":"Stiegler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanessa","family":"Stadlbauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michaela","family":"Schwarz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karlheinz","family":"Tscheliessnigg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.trim.2006.02.001_bib1","doi-asserted-by":"crossref","first-page":"3069","DOI":"10.1016\/j.transproceed.2003.10.041","article-title":"Challenges in heart transplantation: now and the future","volume":"35","author":"Gambino","year":"2003","journal-title":"Transplant Proc"},{"issue":"S3A","key":"10.1016\/j.trim.2006.02.001_bib2","doi-asserted-by":"crossref","first-page":"27S","DOI":"10.1016\/S0041-1345(00)00862-9","article-title":"Neural use in the cardiac transplant recipients","volume":"32","author":"Valantine","year":"2000","journal-title":"Transplant Proc"},{"key":"10.1016\/j.trim.2006.02.001_bib3","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1097\/01.TP.0000103740.98095.14","article-title":"Mycophenolate Mofetil and Sirolimus as calcineurin inhibitor-free immunsuppression for late cardiac-transplant recipients with chronic renal failure","volume":"77","author":"Groetzner","year":"2004","journal-title":"Transplantation"},{"key":"10.1016\/j.trim.2006.02.001_bib4","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1097\/00007890-198707000-00027","article-title":"Cyclosporin-induced acute renal dysfunction in the rat. Evidence of ateriolar vasoconstruction with preservation of tubular function","volume":"44","author":"English","year":"1987","journal-title":"Transplantation"},{"issue":"Suppl. 2","key":"10.1016\/j.trim.2006.02.001_bib5","doi-asserted-by":"crossref","first-page":"229S","DOI":"10.1016\/j.transproceed.2004.01.021","article-title":"Cyclosporine nephrotoxicity","volume":"36","author":"Busauschina","year":"2004","journal-title":"Transplant Proc"},{"key":"10.1016\/j.trim.2006.02.001_bib6","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1034\/j.1399-0012.2002.01119.x","article-title":"Calcineurin inhibitor nephrotoxicity: reduction in dose results in marked improvement in renal function in patients with coexisting chronic allograft nephropathy","volume":"16","author":"Pilmore","year":"2002","journal-title":"Clin Transplant"},{"key":"10.1016\/j.trim.2006.02.001_bib7","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/S0140-6736(89)90417-0","article-title":"Rapamycin for immunosuppressant in organ allografting","volume":"2","author":"Calne","year":"1989","journal-title":"Lancet"},{"key":"10.1016\/j.trim.2006.02.001_bib8","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1097\/00007890-199911270-00016","article-title":"Sirolimus reduces the incidence of acute rejection episodes despite lower cyclosporine doses in Caucasian recipients of mismatched primary renal allografts: a phase II trial","volume":"68","author":"Kahan","year":"1999","journal-title":"Transplantation"},{"key":"10.1016\/j.trim.2006.02.001_bib9","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1097\/00007890-199102000-00041","article-title":"Production of synergistic but nonidentical mechanisms of immunosuppression by rapamycin and cyclosporine","volume":"51","author":"Kimball","year":"1991","journal-title":"Transplantation"},{"key":"10.1016\/j.trim.2006.02.001_bib10","doi-asserted-by":"crossref","first-page":"3221","DOI":"10.1016\/S0041-1345(01)02370-3","article-title":"Rapamycin reduces rejection in heart transplant recipients","volume":"33","author":"Radovancevic","year":"2001","journal-title":"Transplant Proc"},{"key":"10.1016\/j.trim.2006.02.001_bib11","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1111\/j.1600-6143.2005.00757.x","article-title":"First experience with de-novo calcineurin inhibitor free immunosuppression following cardiac transplantation","volume":"5","author":"Meiser","year":"2005","journal-title":"Am J Transplant"},{"key":"10.1016\/j.trim.2006.02.001_bib12","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1056\/NEJMoa022171","article-title":"Everolimus for prevention of allograft rejection and vasculopathy in cardiac-transplant recipients","volume":"9","author":"Eisen","year":"2003","journal-title":"NEJM"},{"key":"10.1016\/j.trim.2006.02.001_bib13","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1016\/S1053-2498(02)01221-4","article-title":"Everolimus in de novo cardiac transplantation: pharmacokinetics, therapeutic range, and influence on cyclosporine exposure","volume":"22","author":"Kovarik","year":"2004","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.trim.2006.02.001_bib14","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.healun.2004.03.010","article-title":"Optimizing the immunosupressive regime in heart transplantation","volume":"23","author":"Eisen","year":"2004","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.trim.2006.02.001_bib15","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/S1053-2498(03)00059-7","article-title":"Risk factors for recurrent rejection in pediatric heart transplantation: a multicenter experience","volume":"23","author":"Chin","year":"2004","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.trim.2006.02.001_bib16","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1097\/00007890-199707150-00007","article-title":"SDZ RAD, a new rapamycin derivative: synergism with cyclosporine","volume":"64","author":"Schuurman","year":"1997","journal-title":"Transplantation"},{"key":"10.1016\/j.trim.2006.02.001_bib17","first-page":"S1, 8","article-title":"48months follow up: Everolimus in cardiac transplantation","volume":"18","author":"Hare","year":"2005","journal-title":"Transpl Int"},{"key":"10.1016\/j.trim.2006.02.001_bib18","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1111\/j.1600-6143.2004.00389.x","article-title":"Everolimus with optimised cyclosporine dosing in renal transplant recipients: 6month safety and efficacy results of two randomised studies","volume":"4","author":"Vitko","year":"2004","journal-title":"Am J Transplant"},{"key":"10.1016\/j.trim.2006.02.001_bib19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/01.TP.0000140486.97461.49","article-title":"Everolimus and reduced-exposure cyclosporine in de-novo renal transplant recipients: a 3-year phase II, randomized, multicenter, open label study","volume":"78","author":"Nashan","year":"2004","journal-title":"Transplantation"},{"key":"10.1016\/j.trim.2006.02.001_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.healun.2004.11.165","article-title":"Evaluation of cyclosporine (CsA) profiles month 2 to 6 in an international phase II randomized, multicenter, double-blind study of everolimus in de novo heart transplant recipients","volume":"24","author":"Eisen","year":"2005","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.trim.2006.02.001_bib21","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1111\/j.1399-0012.2005.00408.x","article-title":"The natural history of renal function following orthotopic heart transplant","volume":"19","author":"Al Aly","year":"2005","journal-title":"Clin Transplant"},{"key":"10.1016\/j.trim.2006.02.001_bib22","doi-asserted-by":"crossref","first-page":"S206","DOI":"10.1016\/j.healun.2005.01.021","article-title":"Clinical experience with Certican (Everolimus) in maintenance heart transplant patients at the medical university of Vienna","volume":"45","author":"Zuckermann","year":"2005","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.trim.2006.02.001_bib23","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1097\/00007890-200203270-00016","article-title":"Exposure\u2013response relationships for everolimus in de-novo kidney transplantation: defining a therapeutic range","volume":"73","author":"Kovarik","year":"2002","journal-title":"Transplantation"},{"key":"10.1016\/j.trim.2006.02.001_bib24","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1111\/j.1399-0012.2005.00326.x","article-title":"Therapeutic drug monitoring for everolimus in kidney transplant recipients based on exposure-efficacy and safety modelling of 12 month data","volume":"19","author":"Lorber","year":"2004","journal-title":"Clin Transplant"},{"key":"10.1016\/j.trim.2006.02.001_bib25","first-page":"S124","article-title":"Transplant coronary disease: nonimmunologic risk factors","volume":"11","author":"Johnson","year":"1992","journal-title":"J Heart Lung Transplant"}],"container-title":["Transplant Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0966327406000165?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0966327406000165?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,17]],"date-time":"2019-01-17T08:51:08Z","timestamp":1547715068000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0966327406000165"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,6]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2006,6]]}},"alternative-id":["S0966327406000165"],"URL":"https:\/\/doi.org\/10.1016\/j.trim.2006.02.001","relation":{},"ISSN":["0966-3274"],"issn-type":[{"value":"0966-3274","type":"print"}],"subject":[],"published":{"date-parts":[[2006,6]]}}}